Close
Nordic 9Nordic 9

Brohuvudet (investor - Private Equity)

Sweden
See something wrong or missing? Let us know
Offices:Stockholm

Brohuvudet AB offers management of securities, real estate, renting of machinery and equipment and business advice services. The company is based in Stockholm, Sweden.

Average round investment:33.9M USD
Average number per year:1.0
Distribution: 2016 (1)
Portfolio companies: Sweden OxThera
Mostly invests in: Sweden Sweden (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Brohuvudet

Name Criteria
Sweden AP4 - Fjärde AP-fonden
62%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
Sweden Bengt Julander
62%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
Sweden Flerie Invest
62%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
United Kingdom Rosetta Capital
62%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
Netherlands LSP (Life Sciences Partners)
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.4
Norway Ferd Capital
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.4
Denmark Sunstone Life Science Ventures
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.5
Sweden HealthCap
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.6
Denmark Lundbeckfond Ventures
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.6
France Kurma Life Science Partners
61%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
Top